packageTivozanib

tivozanib

Extends from Pharmacolibrary.Interfaces.PartialSubstance (Identity and physicochemical constants of one drug (Drugs.Substances)).

Information

Tivozanib is a VEGFR tyrosine kinase inhibitor used to treat advanced renal cell carcinoma. It is authorised in the European Union, but its use is not widespread.

Summary written by glm-5.3-flash from Wikidata Q7810457 and the WHO ATC classification and the EMA medicines list; not checked by a person.

name:tivozanib
ATC codes:L01EK03
DrugBank:DB11800
PubChem CID:9911830
ChEBI:91327
Wikidata:Q7810457
formula:C22H19ClN4O5
molar mass:454.867 g/mol (PubChem CID 9911830)
logP:4 (Drugs.Common 25.09, not verified)

Parameters

TypeNameDefaultDescription
Stringname (from PartialSubstance)""INN / common name
String[:]atcCodes (from PartialSubstance)fill("", 0)all WHO ATC codes of the drug
StringdrugbankId (from PartialSubstance)""e.g. DB00758
StringpubchemCid (from PartialSubstance)""PubChem compound id
StringchebiId (from PartialSubstance)""ChEBI id (number)
StringwikidataId (from PartialSubstance)""e.g. Q410238
Stringformula (from PartialSubstance)""molecular formula
Modelica.Units.SI.MolarMassM (from PartialSubstance)0molar mass; 0 = unknown
ReallogP (from PartialSubstance)Modelica.Constants.infoctanol-water partition coefficient (log10); inf = unknown